What is Lightship?
Lightship specializes in the design and execution of decentralized (DCT) and hybrid clinical trials, aiming to enhance inclusivity and accessibility in medical research. By dismantling traditional geographic and cultural barriers, the company employs a community-based strategy that integrates advanced digital connectivity with physical touchpoints. This innovative approach is realized through a multi-faceted delivery system, including Mobile Research Units (MRUs) – mobile clinics brought directly to patient neighborhoods – and a network of dedicated Mobile Nurses who conduct study visits in participants' homes, thereby reducing the burden on patients and expanding trial reach.
How much funding has Lightship raised?
Lightship has raised a total of $64.9M across 3 funding rounds:
Series A
$4.9M
Series B
$20M
Unspecified
$40M
Series A (2019): $4.9M, investors not publicly disclosed
Series B (2020): $20M led by Marc Benioff, Khosla Ventures, McKesson, Brook Byers, and Define Ventures Management
Unspecified (2021): $40M supported by Define Ventures Management, McKesson, TIME Ventures, and Khosla Ventures
Key Investors in Lightship
Khosla Ventures
Khosla Ventures is a venture capital firm founded in 2004, known for investing in breakthrough technologies across various sectors including health and enterprise. They provide venture assistance and strategic advice to entrepreneurs.
McKesson
McKesson Corporation is a global leader in healthcare supply chain management, pharmaceuticals, and medical supplies, providing a wide range of solutions to healthcare providers and pharmacies.
Define Ventures Management
Define Ventures is an early-stage venture capital firm established in 2019, with a strategic focus on investing in innovative digital health companies.
What's next for Lightship?
The substantial enterprise-level backing positions Lightship for accelerated growth and further innovation in the clinical trial sector. With a focus on expanding its reach and enhancing its technological infrastructure, the company is poised to further solidify its market leadership in decentralized and hybrid trial solutions. Future strategic investments will likely target the scaling of its mobile unit fleet, the expansion of its nurse network, and the continued development of its digital platform to support a growing portfolio of clinical studies. This strategic financing will enable Lightship to capture a larger share of the evolving clinical research landscape, making trials more patient-centric and efficient.
See full Lightship company page
